```html

Extraventricular Brain Hemorrhage – A Comprehensive Medical Guide

Overview

Extraventricular brain hemorrhage (EBH) refers to bleeding that occurs in the brain parenchyma outside the ventricular system. It is a type of intracerebral hemorrhage (ICH) that does not extend into the lateral, third, or fourth ventricles. The blood accumulates within the cerebral tissue, causing mass effect, edema, and direct neuronal injury.

Who it affects: EBH can affect people of any age, but the majority of cases occur in adults over 55 years old. Women and men are affected roughly equally, although some epidemiologic data show a slight male predominance (≈55% men).

Prevalence: Intracerebral hemorrhage accounts for about 10‑15% of all strokes worldwide, and extraventricular hemorrhages make up roughly 30‑40% of those ICHs (≈3‑5% of all strokes). In the United States, an estimated 35,000–45,000 people experience EBH each year, with a case‑fatality rate of 30‑50% within the first month (source: CDC, Mayo Clinic).

Symptoms

Symptoms depend on the size of the bleed, its exact location, and how quickly it expands. Common presenting features include:

• Sudden, severe headache – often described as “the worst headache of my life.”
• Neurological deficits – weakness or numbness on one side of the body (hemiparesis), difficulty speaking (aphasia), facial droop, or loss of coordination.
• Altered consciousness – ranging from confusion and drowsiness to coma.
• Seizures – especially if the hemorrhage irritates cortical tissue.
• Nausea and vomiting – due to increased intracranial pressure.
• Vision changes – double vision, loss of peripheral vision, or eye movement abnormalities.
• Balance and gait disturbances – unsteady walking, frequent falls.
• Speech difficulties – slurred speech (dysarthria) or inability to form words.
• Sudden personality or behavioral changes – especially with frontal‑lobe involvement.

Because symptoms appear abruptly, any sudden neurological change should be treated as a medical emergency.

Causes and Risk Factors

Primary (spontaneous) causes

• Hypertension – chronic uncontrolled high blood pressure weakens small penetrating arteries, leading to rupture. Hypertension is responsible for up to 60% of spontaneous EBH cases.
• Cerebral amyloid angiopathy (CAA) – deposition of amyloid in vessel walls, more common in people >70 y, often causes lobar hemorrhages.
• Coagulopathy – either inherited (e.g., hemophilia) or acquired (e.g., liver disease, vitamin K deficiency).
• Anticoagulant or antiplatelet therapy – warfarin, direct oral anticoagulants (DOACs), aspirin, clopidogrel increase bleeding risk, especially when INR is supratherapeutic.
• Vascular malformations – arteriovenous malformations (AVMs), cavernous malformations, or dural arteriovenous fistulas.
• Brain tumors – especially highly vascular tumors (glioblastoma, metastases) that bleed spontaneously.

Secondary (traumatic) causes

• Closed head injury (e.g., fall, motor‑vehicle collision) that directly damages brain tissue.
• Penetrating trauma (e.g., gunshot– or stab wound).

Risk factors

• Age > 55 years
• Long‑standing hypertension (≥ 140/90 mm Hg)
• Male sex (modest increased risk)
• African‑American or Hispanic ethnicity (higher prevalence of uncontrolled hypertension)
• Heavy alcohol use (> 3 drinks/day)
• Smoking
• Use of illicit drugs (cocaine, methamphetamine) that acutely elevate blood pressure
• Chronic renal insufficiency
• Family history of intracerebral hemorrhage or cerebral amyloid angiopathy

Diagnosis

Rapid diagnosis is essential to limit secondary brain injury. The typical diagnostic pathway includes:

Initial clinical assessment

• Focused neurological exam (NIH Stroke Scale)
• Blood pressure measurement, glucose check, coagulation profile (INR, PT, aPTT), platelet count

Neuroimaging

• Non‑contrast CT scan – the gold‑standard initial test. Hyperdense (bright) area within the brain parenchyma confirms acute hemorrhage within minutes of symptom onset.
• CT angiography (CTA) – evaluates for underlying vascular lesions (AVM, aneurysm) and helps in surgical planning.
• Magnetic resonance imaging (MRI) – especially susceptibility‑weighted imaging (SWI) is sensitive for detecting small bleeds, microbleeds, and CAA‑related changes.
• Digital subtraction angiography (DSA) – invasive but offers the highest resolution for identifying treatable vascular malformations.

Laboratory tests

• Complete blood count (CBC) – to assess anemia and platelets.
• Coagulation panel – INR, PT, aPTT, especially important if patient is on anticoagulants.
• Serum electrolytes, renal and liver function – to guide medication dosing.

Scoring systems

Clinicians often use the ICH Score (based on age, Glasgow Coma Scale, ICH volume, intraventricular extension, and infratentorial location) to estimate mortality risk. Though developed for all ICH, it is applicable to EBH when ventricles are not involved.

Treatment Options

Treatment aims to control bleeding, limit edema, prevent re‑bleeding, and support neurological recovery.

Acute medical management

• Blood pressure control – Target systolic BP 140 mm Hg (or lower) per AHA/ASA guidelines, using IV nicardipine, clevidipine, or labetalol.
• Reversal of anticoagulation –
  • Warfarin: vitamin K + 4‑factor prothrombin complex concentrate (PCC) or fresh frozen plasma.
  • DOACs: idarucizumab (for dabigatran) or andexanet‑α (for factor Xa inhibitors) when available.
  • Antiplatelet agents: platelet transfusion is controversial; consider only if surgery is planned.
• Intracranial pressure (ICP) management – Elevate head of bed 30°, consider hypertonic saline or mannitol if signs of herniation appear.
• Seizure prophylaxis – Short‑term levetiracetam is commonly used, especially for lobar or cortical bleeds.
• Glycemic control – Maintain glucose 140‑180 mg/dL.

Surgical and interventional options

• Open craniotomy – Indicated for large, accessible hematomas causing mass effect, especially in the supratentorial region.
• Minimally invasive catheter‑based evacuation – Endoscopic or stereotactic aspiration (e.g., using the MISTIE technique) reduces hematoma volume while sparing healthy tissue.
• Decompressive hemicraniectomy – Reserved for refractory brain swelling with impending herniation.
• Endovascular embolization – For bleeding AVMs or aneurysms identified on CTA/DSA.

Rehabilitation and long‑term management

• Physical, occupational, and speech therapy to address motor, functional, and communication deficits.
• Neuropsychological assessment for cognitive or mood changes.
• Secondary‑stroke prevention (antihypertensive regimen, lipid control, lifestyle modification).

Living with Extraventricular Brain Hemorrhage

Survivors often face a mixture of physical, emotional, and practical challenges. Below are actionable tips for daily life:

• Medication adherence – Use pill organizers, set alarms, and keep a written medication list.
• Blood pressure monitoring – Check at home twice daily; share readings with your healthcare team.
• Fall prevention – Install grab bars, ensure good lighting, use non‑slip mats, and consider a bedside commode if balance is impaired.
• Nutrition – Emphasize a DASH or Mediterranean diet (rich in fruits, vegetables, whole grains, lean protein, low sodium) to support vascular health.
• Physical activity – Engage in low‑impact aerobic exercise (walking, stationary cycling) 150 min/week as tolerated; consult a physiatrist before starting.
• Cognitive exercises – Puzzles, memory apps, or structured cognitive therapy can improve attention and executive function.
• Support network – Join stroke survivor groups, involve family in care planning, and consider counseling for depression or anxiety.
• Driving and work – Obtain formal assessments before resuming driving; discuss workplace accommodations with an occupational therapist.

Prevention

While not all bleeds are preventable, addressing modifiable risk factors can markedly lower your odds of a repeat event.

• Control blood pressure – Aim for <130/80 mm Hg for most adults; use combination therapy if needed.
• Manage anticoagulation wisely – Keep INR in therapeutic range (2‑3 for most indications); discuss DOAC dose adjustments with your physician.
• Quit smoking – Seek nicotine replacement or prescription aids.
• Limit alcohol – No more than 2 drinks/day for men, 1 for women.
• Regular health checks – Annual labs for cholesterol, kidney function, and glucose.
• Healthy weight – BMI 18.5‑24.9 reduces vascular strain.
• Exercise – Consistent aerobic activity improves endothelial function.
• Screen for cerebral amyloid angiopathy – In patients >70 y with lobar ICH, MRI with SWI can identify microbleeds; discuss risk with neurologist.

Complications

If the hemorrhage or its treatment is not adequately managed, several serious complications may arise:

• Increased intracranial pressure & herniation – Can be fatal within hours.
• Re‑bleeding – Particularly in patients with uncontrolled hypertension or ongoing coagulopathy.
• Hydrocephalus – Even though the bleed is extraventricular, surrounding edema can obstruct CSF flow.
• Seizure disorder – Chronic epilepsy may develop, requiring long‑term antiepileptic therapy.
• Cognitive impairment – Memory, attention, and executive function deficits.
• Motor disability – Persistent weakness, spasticity, or gait disturbance.
• Depression & anxiety – Affect up to 40% of stroke survivors.
• Secondary stroke – Risk of another hemorrhagic or ischemic event remains elevated, especially within the first year.

When to Seek Emergency Care

References

• Mayo Clinic. “Intracerebral hemorrhage.” https://www.mayoclinic.org
• American Heart Association/American Stroke Association. “Guidelines for the Management of Spontaneous Intracerebral Hemorrhage.” Stroke 2022
• Centers for Disease Control and Prevention. “Stroke Facts.” CDC
• National Institutes of Health. “Cerebral Amyloid Angiopathy.” NINDS
• Cleveland Clinic. “Brain Hemorrhage – Symptoms, Causes, Diagnosis, Treatment.” Cleveland Clinic
• World Health Organization. “Stroke.” WHO

```